close
close

Yiamastaverna

Trusted News & Timely Insights

    • Bio-Techne

    What the SWOT analysis reveals about Bio-Techne Corp (TECH)
    Alabama

    What the SWOT analysis reveals about Bio-Techne Corp (TECH)

    Strengths: Robust product portfolio and strategic acquisitions as growth drivers. Weaknesses: Increased operating costs affect profitability. Opportunities: Expansion into high-growth markets and innovative product development. Threats: Intense competition and regulatory challenges in a dynamic industry. On August 22, 2024, Bio-Techne…

    Posted on Idris Bevan
    Bio-Techne (NASDAQ:TECH) receives buy recommendation from Benchmark
    Alabama

    Bio-Techne (NASDAQ:TECH) receives buy recommendation from Benchmark

    Benchmark reiterated its buy recommendation for shares of Bio-Techne (NASDAQ:TECH – Free Report) in a research note published on Tuesday, Benzinga reports. The brokerage currently has a price target of $95.00 on the biotechnology company’s stock. Several other brokerage firms…

    Posted on Idris Bevan
    Bio-Techne (NASDAQ:TECH) receives buy recommendation from Benchmark
    Alabama

    Royal Bank of Canada lowers Bio-Techne (NASDAQ:TECH) price target to USD 70.00

    Bio-Techne (NASDAQ:TECH – Free Report) The price target was cut by Royal Bank of Canada from $72.00 to $70.00 in a research note published on Thursday, Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the…

    Posted on Idris Bevan
    Bio-Techne (NASDAQ:TECH) reports results
    Alabama

    Bio-Techne (NASDAQ:TECH) reports results

    Bio-Techne (NASDAQ:TECH – Get Free Report) reported its quarterly results on Wednesday. The biotechnology company reported earnings per share (EPS) of $0.49 for the quarter, meeting analysts’ consensus estimates of $0.49, Briefing.com reports. Bio-Techne had a net margin of 17.59%…

    Posted on Idris Bevan

    ads